We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Amsterdam Molecular Therapeutics Enters Research Collaboration with the University of Barcelona

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Amsterdam Molecular Therapeutics BV (AMT) has announced that it will undertake collaborative research activities in the area of gene regulation of fatty acid oxidation and obesity with the University of Barcelona, Spain.

The research group will be led by Professor Fausto G. Hegardt, Professor of Biochemistry and head of the Laboratory at the School of Pharmacy of the University of Barcelona.

The research will focus on development of a gene therapy capable of regulating mitochondrial fatty acid metabolism and insulin resistance.

The collaboration will initially aim to demonstrate the safety and efficacy of the product various preclinical models. If successful the product will be taken into clinical development and commercialization.